The Sports Supplement decision has been released. Below is an overview summary breakdown of the effects of the decision. Please read today's full member alert for more information about the decision and RIS for Sponsors and Manufacturers.
Essential Summary breakdown of effected products:
|
"Therapeutic Goods" from 30 November 2023
TABLETS, CAPSULES or PILLS for oral administration which are (expressly or implicitly) represented* for the improvement or maintenance of physical or mental performance in sport, exercise or recreational activity.
|
|
"Therapeutic Goods" from commencement (30 November 2020):
ANY PRODUCT for oral administration which is (expressly or implicitly) represented for the improvement or maintenance of physical or mental performance in sport, exercise or recreational activity
and which contain (or are represented expressly or implicitly to contain) substances that are
Scheduled substances in the Poisons Standard, or
the World Anti-Doping Code International Standard Prohibited List (January 2020), or
a relevant substance (a) dendrobium (Dendrobium nobile); or (b) methylliberine; or
a substance with equivalent pharmacological action to any of the above.
|
*(includes: gaining muscle; increasing mental focus; increasing metabolism; increasing stamina; increasing testosterone levels; reducing oestrogen levels or otherwise modifying hormone levels; losing weight or fat; preparing for workout; recovering from workout).
